Change in vBMD of Combination Therapy of Teriparatide and Denosumab in Osteoporosis at 18 Months: How Much Difference Does It Make on Spine vBMD?
Key Points
Combination therapy with teriparatide and denosumab significantly improves spine vBMD.
Participants experienced a noteworthy increase in vBMD after 18 months of treatment.
Assessment included measurements of vBMD following therapeutic intervention.
Findings suggest that the combination therapy could enhance bone health in osteoporosis.
Like
Bookmark
Share
Like
Bookmark
Share
Change in vBMD of Combination Therapy of Teriparatide and Denosumab in Osteoporosis at 18 Months: How Much Difference Does It Make on Spine vBMD? | Synapse